Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hydroperoxyl radical (HO2) is a highly reactive oxygen species (ROS) and represents the protonated form of the superoxide anion (O2.-) with a pKa of approximately 4.88 [PubChem]. Because it is a neutral molecule, it possesses significantly greater lipid solubility and membrane permeability compared to the superoxide anion, allowing it to penetrate biological membranes and initiate lipid peroxidation [Free Radical Biology and Medicine]. It is formed through the one-electron reduction of oxygen or the protonation of superoxide in acidic microenvironments, such as the lysosome or during inflammatory and ischemic conditions [Wikipedia]. Pathologically, its accumulation contributes to the oxidative degradation of biological macromolecules, a process implicated in the progression of atherosclerosis, Alzheimer's disease, and various cancers [Nature Reviews Molecular Cell Biology]. While it is not a traditional protein receptor or enzyme, it is the primary target of antioxidant therapies and superoxide dismutase (SOD) mimetics, which aim to neutralize the radical and prevent tissue damage [Journal of Medicinal Chemistry]. Therapeutic challenges in targeting this species include the difficulty of achieving specific organelle localization and the risk of disrupting essential physiological redox signaling pathways [NIH].
Antioxidants and superoxide dismutase (SOD) mimetics work by scavenging the hydroperoxyl radical or catalyzing its dismutation into oxygen and hydrogen peroxide, thereby preventing the initiation of lipid peroxidation and oxidative damage to cellular components [Journal of Medicinal Chemistry].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroperoxyl radical (HO2).